288 related articles for article (PubMed ID: 23012423)
1. MiR-494 is regulated by ERK1/2 and modulates TRAIL-induced apoptosis in non-small-cell lung cancer through BIM down-regulation.
Romano G; Acunzo M; Garofalo M; Di Leva G; Cascione L; Zanca C; Bolon B; Condorelli G; Croce CM
Proc Natl Acad Sci U S A; 2012 Oct; 109(41):16570-5. PubMed ID: 23012423
[TBL] [Abstract][Full Text] [Related]
2. BIM induction of apoptosis triggered by EGFR-sensitive and resistance cell lines of non-small-cell lung cancer.
Li Z; Zhou S; Zhang L; Su C; Hang J; Zhao Y; Su B; Zhou C
Med Oncol; 2011 Jun; 28(2):572-7. PubMed ID: 20237869
[TBL] [Abstract][Full Text] [Related]
3. MiR-92a mediates AZD6244 induced apoptosis and G1-phase arrest of lymphoma cells by targeting Bim.
Lv XB; Zhang X; Deng L; Jiang L; Meng W; Lu Z; Wang X
Cell Biol Int; 2014 Apr; 38(4):435-43. PubMed ID: 24375836
[TBL] [Abstract][Full Text] [Related]
4. Hsa-miR-139-5p inhibits proliferation and causes apoptosis associated with down-regulation of c-Met.
Sun C; Sang M; Li S; Sun X; Yang C; Xi Y; Wang L; Zhang F; Bi Y; Fu Y; Li D
Oncotarget; 2015 Nov; 6(37):39756-92. PubMed ID: 26497851
[TBL] [Abstract][Full Text] [Related]
5. Role of ERK-BIM and STAT3-survivin signaling pathways in ALK inhibitor-induced apoptosis in EML4-ALK-positive lung cancer.
Takezawa K; Okamoto I; Nishio K; Jänne PA; Nakagawa K
Clin Cancer Res; 2011 Apr; 17(8):2140-8. PubMed ID: 21415216
[TBL] [Abstract][Full Text] [Related]
6. Reduced miR-3127-5p expression promotes NSCLC proliferation/invasion and contributes to dasatinib sensitivity via the c-Abl/Ras/ERK pathway.
Sun Y; Chen C; Zhang P; Xie H; Hou L; Hui Z; Xu Y; Du Q; Zhou X; Su B; Gao W
Sci Rep; 2014 Oct; 4():6527. PubMed ID: 25284075
[TBL] [Abstract][Full Text] [Related]
7. miR-130a targets MET and induces TRAIL-sensitivity in NSCLC by downregulating miR-221 and 222.
Acunzo M; Visone R; Romano G; Veronese A; Lovat F; Palmieri D; Bottoni A; Garofalo M; Gasparini P; Condorelli G; Chiariello M; Croce CM
Oncogene; 2012 Feb; 31(5):634-42. PubMed ID: 21706050
[TBL] [Abstract][Full Text] [Related]
8. Luteolin Inhibits Tumorigenesis and Induces Apoptosis of Non-Small Cell Lung Cancer Cells via Regulation of MicroRNA-34a-5p.
Jiang ZQ; Li MH; Qin YM; Jiang HY; Zhang X; Wu MH
Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29393891
[TBL] [Abstract][Full Text] [Related]
9. Sustained activation of ERK1/2 by NGF induces microRNA-221 and 222 in PC12 cells.
Terasawa K; Ichimura A; Sato F; Shimizu K; Tsujimoto G
FEBS J; 2009 Jun; 276(12):3269-76. PubMed ID: 19438724
[TBL] [Abstract][Full Text] [Related]
10. Colorectal cancer cells with the BRAF(V600E) mutation are addicted to the ERK1/2 pathway for growth factor-independent survival and repression of BIM.
Wickenden JA; Jin H; Johnson M; Gillings AS; Newson C; Austin M; Chell SD; Balmanno K; Pritchard CA; Cook SJ
Oncogene; 2008 Dec; 27(57):7150-61. PubMed ID: 18806830
[TBL] [Abstract][Full Text] [Related]
11. Oncogenic kit triggers Shp2/Erk1/2 pathway to down-regulate the pro-apoptotic protein Bim and to promote apoptosis resistance in leukemic cells.
Selimoglu-Buet D; Gallais I; Denis N; Guillouf C; Moreau-Gachelin F
PLoS One; 2012; 7(11):e49052. PubMed ID: 23145067
[TBL] [Abstract][Full Text] [Related]
12. [MiR-192 confers cisplatin resistance by targeting Bim in lung cancer].
Zhang F; Li Y; Wu H; Qi K; You J; Li X; Zu L; Pan Z; Wang Y; Li Y; Li Y; Wang M; Shen W; Zhou Q
Zhongguo Fei Ai Za Zhi; 2014 May; 17(5):384-90. PubMed ID: 24854555
[TBL] [Abstract][Full Text] [Related]
13. miR-103 Functions as a Tumor Suppressor by Directly Targeting Programmed Cell Death 10 in NSCLC.
Yang D; Wang JJ; Li JS; Xu QY
Oncol Res; 2018 May; 26(4):519-528. PubMed ID: 28734041
[TBL] [Abstract][Full Text] [Related]
14. MiR-760 enhances TRAIL sensitivity in non-small cell lung cancer via targeting the protein FOXA1.
Zhang X; Wang L; Liu Y; Huang W; Cheng D
Biomed Pharmacother; 2018 Mar; 99():523-529. PubMed ID: 29665655
[TBL] [Abstract][Full Text] [Related]
15. Gefitinib-induced killing of NSCLC cell lines expressing mutant EGFR requires BIM and can be enhanced by BH3 mimetics.
Cragg MS; Kuroda J; Puthalakath H; Huang DC; Strasser A
PLoS Med; 2007 Oct; 4(10):1681-89; discussion 1690. PubMed ID: 17973573
[TBL] [Abstract][Full Text] [Related]
16. EZH2-mediated Puma gene repression regulates non-small cell lung cancer cell proliferation and cisplatin-induced apoptosis.
Liu H; Li W; Yu X; Gao F; Duan Z; Ma X; Tan S; Yuan Y; Liu L; Wang J; Zhou X; Yang Y
Oncotarget; 2016 Aug; 7(35):56338-56354. PubMed ID: 27472460
[TBL] [Abstract][Full Text] [Related]
17. miR-942 decreases TRAIL-induced apoptosis through ISG12a downregulation and is regulated by AKT.
Liu N; Zuo C; Wang X; Chen T; Yang D; Wang J; Zhu H
Oncotarget; 2014 Jul; 5(13):4959-71. PubMed ID: 24970806
[TBL] [Abstract][Full Text] [Related]
18. Effects of ebv-miR-BART7 on tumorigenicity, metastasis, and TRAIL sensitivity of non-small cell lung cancer.
Wang L; Liu LF; Zhou L; Liao F; Wang J
J Cell Biochem; 2019 Jun; 120(6):10057-10068. PubMed ID: 30569505
[TBL] [Abstract][Full Text] [Related]
19. MEK Inhibition Overcomes Cisplatin Resistance Conferred by SOS/MAPK Pathway Activation in Squamous Cell Carcinoma.
Kong LR; Chua KN; Sim WJ; Ng HC; Bi C; Ho J; Nga ME; Pang YH; Ong WR; Soo RA; Huynh H; Chng WJ; Thiery JP; Goh BC
Mol Cancer Ther; 2015 Jul; 14(7):1750-60. PubMed ID: 25939760
[TBL] [Abstract][Full Text] [Related]
20. Gossypol induces death receptor-5 through activation of the ROS-ERK-CHOP pathway and sensitizes colon cancer cells to TRAIL.
Sung B; Ravindran J; Prasad S; Pandey MK; Aggarwal BB
J Biol Chem; 2010 Nov; 285(46):35418-27. PubMed ID: 20837473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]